Literature DB >> 8403501

Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis.

J F Schlaak1, H Löhr, H Gallati, K H Meyer zum Büschenfelde, B Fleischer.   

Abstract

The pathogenic mechanisms underlying the development of autoimmune hepatitis (AIH) are still unclear. Since AIH is associated with the presence of various autoantibodies and certain HLA subtypes, it is likely that T and B cells play a major role in this disease. In this study we have determined the functional capacities of in vivo preactivated liver-infiltrating T cells (LTC) from patients with AIH. As controls we used LTC from patients with non-autoimmune hepatitis (non-AIH). Our results show that preactivated LTC from patients with AIH predominantly (190/255 clones) reside in the CD4+ population, whereas LTC in non-AIH are dominated by the CD8+ phenotype (148/254 clones). In view of this finding we have investigated the cytokine secretion patterns of 102 randomly chosen CD4+ T cell clones from six patients with AIH. As controls we have used 58 CD4+ LTC from 11 patients with non-AIH. All clones were stimulated by lectin and irradiated accessory cells and subsequent cytokine production was evaluated. LTC from patients with AIH have a lower interferon-gamma (IFN-gamma)/IL-4 ratio compared with LTC from non-AIH. Although clones from some patients with AIH produced very high amounts of IL-4 in vitro, this was not a constant finding. These results show that in vivo preactivated LTC from patients with AIH are mostly CD4+ T cells that produce more IL-4 than IFN-gamma. In contrast, LTC from patients with non-AIH are dominated by CD8+ and CD4+ T cells that produce significantly less IL-4 than IFN-gamma. Thus, liver-infiltrating T cells from patients with AIH and non-AIH belong to different functional T cell subsets. This may have implications for the regulation of humoral and cellular immune responses in inflammatory liver disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403501      PMCID: PMC1534365          DOI: 10.1111/j.1365-2249.1993.tb05996.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma.

Authors:  T F Gajewski; J Joyce; F W Fitch
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

2.  Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies.

Authors:  J Loeper; V Descatoire; M Maurice; P Beaune; J Belghiti; D Houssin; F Ballet; G Feldmann; F P Guengerich; D Pessayre
Journal:  Gastroenterology       Date:  1993-01       Impact factor: 22.682

3.  Interferon-gamma inhibits the action of B cell stimulatory factor (BSF)-1 on resting B cells.

Authors:  E M Rabin; J J Mond; J Ohara; W E Paul
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

4.  Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones.

Authors:  X Paliard; R de Waal Malefijt; H Yssel; D Blanchard; I Chrétien; J Abrams; J de Vries; H Spits
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

5.  Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.

Authors:  T F Gajewski; F W Fitch
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

6.  A new murine CD4+ T cell subset with an unrestricted cytokine profile.

Authors:  G S Firestein; W D Roeder; J A Laxer; K S Townsend; C T Weaver; J T Hom; J Linton; B E Torbett; A L Glasebrook
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

7.  Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.

Authors:  H F Eggink; H J Houthoff; S Huitema; C H Gips; S Poppema
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

8.  Inhibition of B lymphocyte activation by interferon-gamma.

Authors:  D S Reynolds; W H Boom; A K Abbas
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

9.  Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.

Authors:  H M Cherwinski; J H Schumacher; K D Brown; T R Mosmann
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness.

Authors:  E A Kurt-Jones; S Hamberg; J Ohara; W E Paul; A K Abbas
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

View more
  18 in total

1.  Exacerbated autoimmune hepatitis successfully treated with leukocytapheresis and bilirubin adsorption therapy.

Authors:  K Sawada; K Ohnishi; T Kosaka; S Chikano; A Egashira; M Okui; S Shintani; M Wada; K Nakasho; T Shimoyama
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

Review 2.  Autoantibody-negative autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-12-21       Impact factor: 3.199

3.  HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines.

Authors:  J F Schlaak; G Tully; H F Löhr; G Gerken; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

4.  Nature and behavior of serum cytokines in type 1 autoimmune hepatitis.

Authors:  A J Czaja; C Sievers; N N Zein
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

Review 5.  Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2018-04-18       Impact factor: 3.199

Review 6.  Autoimmune hepatitis. Definition--classification--histopathology--immunopathogenesis.

Authors:  K H Meyer zum Büschenfelde; H P Dienes
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

7.  Increased bcl-2 expression in lymphocytes and its association with hepatocellular damage in patients with autoimmune hepatitis.

Authors:  M Yachida; K Kurokohchi; K Arima; M Nishioka
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

8.  Association of HLA-DR14 with the treatment response in Japanese patients with autoimmune hepatitis.

Authors:  Yoshiyuki Suzuki; Kenji Ikeda; Miharu Hirakawa; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Tetsuya Hosaka; Norio Akuta; Masahiro Kobayashi; Fumitaka Suzuki; Satoshi Saitoh; Yasuji Arase; Mariko Kobayashi; Yuzo Miyakawa; Hiromitsu Kumada
Journal:  Dig Dis Sci       Date:  2010-01-22       Impact factor: 3.199

9.  Posttransfusional, LKM-1-autoantibody-positive hepatitis C virus infection, cryoglobulinemia, and aplastic anemia.

Authors:  M Peters; M Trippler; H Löhr; W Gödderz; W Herr; S Störkel; K H Meyer zum Büschenfelde; G Gerken
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

10.  Immune responses in autoimmune hepatitis: effect of prednisone and azathioprine treatment: case report.

Authors:  Martin H Bluth; Stephan Kohlhoff; Kevin B Norowitz; Jonathan I Silverberg; Seto Chice; M Nowakowski; Helen G Durkin; Tamar A Smith-Norowitz
Journal:  Int J Med Sci       Date:  2009-06-30       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.